search
NYSE:LLY
USD
787.02
- (3.2%)
ELI LILLY AND COMPANY
Industry: Drug Manufacturers - General
End of Day: 15 May 2024 GMT-4
USD 787.02
- (3.2%)
End of Day: 15 May 2024 GMT-4
Industry: Drug Manufacturers - General

Quote

Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-

Company Info

more

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and...

Key Ratios

more

Income

more

Balance Sheet

more

Cash Flow

more

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices